Westfield Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $32.2M | Buy |
|
|||||
|
2024
Q4 | $59.3M | Buy |
|
|||||
|
2024
Q3 | $83M | Buy |
|
|||||
|
2024
Q2 | $93.2M | Buy |
|
|||||
|
2024
Q1 | $107M | Buy |
|
|||||
|
2023
Q4 | $118M | Sell |
|
|||||
|
2023
Q3 | $85.9M | Buy |
|
|||||
|
2023
Q2 | $72.6M | Buy |
|
|||||
|
2023
Q1 | $55.4M | Buy |
|
|||||
|
2022
Q4 | $56.9M | Buy |
|
|||||
|
2022
Q3 | $42.3M | Sell |
|
|||||
|
2022
Q2 | $46.1M | Buy |
|
|||||
|
2022
Q1 | $34.8M | Buy |
|
|||||
|
2021
Q4 | $44.5M | Buy |
|
|||||
|
2021
Q3 | $60.6M | Sell |
|
|||||
|
2021
Q2 | $92M | Buy |
|
|||||
|
2021
Q1 | $73.8M | Buy |
|
|||||
|
2020
Q4 | $87.5M | Buy |
|
|||||
|
2020
Q3 | $34.3M | Sell |
|
|||||
|
2020
Q2 | $35.8M | Buy |
|
|||||
|
2020
Q1 | $23.5M | Buy |
|
|||||
|
2019
Q4 | $18.2M | Buy |
|
|||||
|
2019
Q3 | $9.16M | Buy |
|
|||||
|
2019
Q2 | $8.46M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $367K | Buy |
|